Literature DB >> 28349639

Metabolic mediators of the impact of general and central adiposity measures on cardiovascular disease and mortality risks in older adults: Tehran Lipid and Glucose Study.

Sara Kazempour-Ardebili1, Azra Ramezankhani1, Ali Eslami1, Samaneh Akbarpour1,2, Fereidoun Azizi3, Farzad Hadaegh1.   

Abstract

AIMS: To investigate the relationship between body mass index, waist circumference, waist-to-hip ratio and waist-to-height ratio, as well as the mediating factors through which they might exert their risk for cardiovascular disease/coronary heart disease and mortality events in the older Iranian population during a median follow up of 9.5 years.
METHODS: The study population included participants, aged ≥65 years, free of cardiovascular disease at baseline. The confounder-adjusted hazard ratio was calculated for a 1-SD change in each anthropometric measure with and without adjustment for hypercholesterolemia, diabetes and hypertension.
RESULTS: During the study follow up, 193 participants developed their first cardiovascular disease event and 183 deaths occurred. No association was found between cardiovascular disease/coronary heart disease and body mass index, even in the confounder-adjusted models. Central adiposity measures showed a significant risk for cardiovascular disease events in the confounder-adjusted model ranging from hazard ratio 1.16 (95% confidence interval 1.02-1.33) for waist-to-hip ratio to 1.21 (95% confidence interval 1.03-1.42) for waist-to-height ratio. Adjustment for hypertension alone or in combination with other metabolic mediators attenuated the hazard ratio to null. Although hypercholesterolemia did not show any mediating effect of central adiposity measures for cardiovascular disease/coronary heart disease, hypertension was the most powerful mediator, accounting for 30-45% of the excess risk.
CONCLUSIONS: Central rather than general adiposity showed a significant role in determining cardiovascular disease/coronary heart disease risk. The harmful effect of central adiposity was completely attributable to mediators, especially hypertension. Clinical interventions for control of mediators focusing on hypertension should be emphasized. Geriatr Gerontol Int 2017; 17: 2017-2024.
© 2017 Japan Geriatrics Society.

Entities:  

Keywords:  cardiovascular disease; elderly; excess risk; mediator effect

Mesh:

Year:  2017        PMID: 28349639     DOI: 10.1111/ggi.13015

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  4 in total

1.  Associations of anthropometric adiposity indexes with hypertension risk: A systematic review and meta-analysis including PURE-China.

Authors:  Guijuan Deng; Lu Yin; Weida Liu; Xiaoyun Liu; Quanyong Xiang; Zhenzhen Qian; Juntao Ma; Hui Chen; Yang Wang; Bo Hu; Wei Li; Yu Jiang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

Review 2.  Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS).

Authors:  Hengameh Abdi; Atieh Amouzegar; Maryam Tohidi; Fereidoun Azizi; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-20

3.  Contribution of obesity and cardiometabolic risk factors in developing cardiovascular disease: a population-based cohort study.

Authors:  Mahmood Bakhtiyari; Elham Kazemian; Kourosh Kabir; Farzad Hadaegh; Sepehr Aghajanian; Parham Mardi; Nooshin Taherzadeh Ghahfarokhi; Ali Ghanbari; Mohammad Ali Mansournia; Freidoun Azizi
Journal:  Sci Rep       Date:  2022-01-28       Impact factor: 4.379

4.  Different body parts' fat mass and corrected QT interval on the electrocardiogram: The Fasa PERSIAN Cohort Study.

Authors:  Mohammad Hosein Yazdanpanah; Ehsan Bahramali; Mohammad Mehdi Naghizadeh; Mojtaba Farjam; Maryam Mobasheri; Shiva Dadvand
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.